ACP treatment guideline for antidepressants

Elliott, William T.
January 2009
Travel Medicine Advisor;Jan2009 Supplement, p2
The article reports on a practice guideline issued by the American College of Physicians for the use of antidepressants to treat depressive disorders. The guideline covers the use of newer second-generation antidepressants, including fluoxetine, sertraline and paroxetine. It recommends that second-generation antidepressants should be selected on the basis of adverse effect profiles, cost and patient preference.


Related Articles

  • ACP treatment guideline for antidepressants.  // Clinical Oncology Alert;Jan2009 Pharmacology Watch, p2 

    The article reports on a practice guideline issued by the American College of Physicians for the use of antidepressants to treat depressive disorders. The guideline covers the use of newer second-generation antidepressants, such as fluoxetine, sertaline, fluvoxamine, among others. It recommends...

  • [Commentary on] Fluoxetine and sertraline may be associated with lower risk of suicide death than paroxetine in adults with depression. Shah, Ajit; Bhat, Ravi // Evidence Based Mental Health;Nov2012, Vol. 15 Issue 4, p98 

    The authors comment on a study comparing the effectiveness of Fluoxetine and Sertraline with paroxetine in reducing the risk of suicide deaths in individuals from the Veterans Affairs (VA) Health System with depression. The findings suggests that there was no significant differences between the...

  • Placebos in Clinical Trials of Psychotropic Medication. Addington, Donald; Williams, Richard; Lapierre, Yvon; el-Guebaly, Nady // Canadian Journal of Psychiatry;Apr1997, Vol. 42 Issue 3, preceding p313 

    This paper represents the position of the Canadian Psychiatric Association on the ethical and scientific issues related to the use of placebos in the evaluation of new psychotropic drugs. The position taken by the Association is that new psychotropic medications must be shown to he effective and...

  • TAKE A CHILL PILL? BRANT, MARTHA // Washingtonian Magazine;Dec2010, Vol. 46 Issue 3, p87 

    The article previews several drugs for anxiety and depression including the antidepressant drugs, Lexapro, Paxil and Zoloft.

  • Which is the safest antidepressant if breast-feeding? Jones, Wendy // Pulse;7/22/2002, Vol. 62 Issue 29, p60 

    Presents information on the safest antidepressant for a breast-feeding patient. Pharmacokinetics and side effects of the tricyclic antidepressants; Details on fluoxentine and sertraline antidepressants.

  • Education: Mental health - Medical management of depression.  // GP: General Practitioner;8/4/2014, p17 

    The article offers tips on how to manage treatment failure in depression, described to be a common presentation in general practice. Topics discussed include the issues surrounding treatment resistance, the different types and levels of depression, and considerations in prescribing medication....

  • Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats. Amodeo, Leslie; Greenfield, Venuz; Humphrey, Danielle; Varela, Veronica; Pipkin, Joseph; Eaton, Shannon; Johnson, Jelesa; Plant, Christopher; Harmony, Zachary; Wang, Li; Crawford, Cynthia // Psychopharmacology;Oct2015, Vol. 232 Issue 19, p3515 

    Rationale: The SSRI antidepressant fluoxetine is one of the few drugs that is effective at treating depression in adolescent humans. In contrast, the SSRI paroxetine has limited efficacy and is more at risk for inducing suicidal behavior. Objective: The purpose of the present study was to more...

  • Evolving Medical Standards. Jackson, Kent S. // Business & Commercial Aviation;Dec2010, Vol. 106 Issue 12, p66 

    The article reports on the announcement of the Federal Aviation Administration (FAA) regarding the issuance of medical certificates to pilots who have been taking any of the four antidepressants they specified for the past 12 months. According to FAA, these antidepressants are fluoxetine...

  • Suicide Watch. Gupta, Sanjay // Time;4/5/2004, Vol. 163 Issue 14, p86 

    Reports that the U.S. Food and Drug Administration warned that people taking antidepressants can become suicidal and should be closely monitored. Suggestion that family members should look for symptoms such as increased anxiety, irritability, hostility, impulsiveness, and restlessness in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics